Cardiovascular – Renal Drugs : Antiplatelets and Thrombolytics
OLICO1 “Licodine FC tablet” 100 mg/tab
適應症：適用於曾發生完全性栓塞型中風（completed thrombotic stroke）及有中風前兆（stroke precursors），且不適於使用aspirin之患者。
Usual dose:
Coronary artery bypass, Stroke prophylaxis: PO, 250 mg bid.
Coronary artery stenting: PO, 250 mg bid for 30 days.
Contraindication:
Active bleeding disorders, neutropenia, thrombocytopenia, severe liver impairment.
Adverse effect:
Common: anorexia, abdominal pain, diarrhea, dyspepsia, nausea, vomiting abnormal LFTs dizziness pruritus, purpura, rash.
Serious: neutropenia, thrombotic thrombocytopenia purpura, aplastic anemia.
健保使用規範：(87/4/1、88/9/1、90/1/1、100/7/1)
1.限無法忍受acetylsalicylic acid (Aspirin) 或對acetylsalicylic acid (Aspirin) 有禁忌而需使用抗血小板製劑之病患使用(88/9/1)。
2.原則上本類製劑與acetylsalicylic acid (Aspirin) 不宜合併使用，僅於冠狀動脈支架植入術後三個月內，得依病情需要合併使用。(87/4/1、90/1/1）
3.申報費用時需註明放置支架 (stent) 之日期。（87/4/1、90/1/1、100/7/1)